Skip to main content
Clinical Trials/NCT01280227
NCT01280227
Completed
Not Applicable

Supporting Patient Provider Communication for Children With Cancer and Congenital Heart Disease

Oslo University Hospital1 site in 1 country144 target enrollmentJanuary 2005

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cancer
Sponsor
Oslo University Hospital
Enrollment
144
Locations
1
Primary Endpoint
Patient-provider communication
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

Children with Cancer or congenital heart disease (CHD) experience complex, physical, psychosocial and behavioural symptoms and problems due to the illness, treatment, and medical procedures. To help children cope with their problems and prevent psychological distress, the investigators developed SiSom, a support system to help children with cancer or CHD report their symptoms and problems in an age-adjusted manner on a touch-pad, portable computer.

This quasi-experimental study with 202 children age 7-12 with CHD or cancer will test the following hypotheses: When children use SiSom to report their symptoms and problems, and this information is provided to their clinicians in their outpatient consultations:

  • Children and parents will experience less anxiety.
  • Children and parents will be more satisfied with the outpatient visit.
  • There will be greater congruence between children's reported symptoms and problems and those addressed by their clinicians as evidenced in documented patient care.

To better understand the mechanisms by which these effects may occur, the investigators will also explore:

  • Differences between control and experimental groups in patient-provider communication in terms of instrumental and affective behaviour, participation, initiative and person addressed;
  • The relationships among outcomes of patient-provider communication, congruence between patients' reported symptoms and those addressed by their clinicians and children's and parents' anxiety and satisfaction; and how these relationships differ between treatment and control conditions.

Finally, the investigators will investigate time requirements, ease of use and usefulness of SiSom by children and clinicians.

For analyses the investigators will use inferential statistics and qualitative analyses of the video-taped consultation sessions. This study will contribute to improving patient-centred care for a particularly vulnerable population, and to a better understanding of the triadic communication and interactions among child-parent and clinician.

Registry
clinicaltrials.gov
Start Date
January 2005
End Date
July 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Oslo University Hospital
Responsible Party
Principal Investigator
Principal Investigator

Cornelia Ruland

Professor

Oslo University Hospital

Eligibility Criteria

Inclusion Criteria

  • Between 7 and 12 years.
  • Ethnic norwegian.
  • Undergoing treatment for cancer or diagnosed with a congenital heart disease.

Exclusion Criteria

  • Receiving or have received radiation the brain as this may affect their abilities to use SiSom and communicate during consultations.
  • Syndromes, mental retardation, developmental disorders, language disorders, or cognitive disorders that affect their ability to report symptoms or communicate during consultations.
  • Other ethnic origin.

Outcomes

Primary Outcomes

Patient-provider communication

Time Frame: Single measure, video recording of medical consultation lasting approximately one hour

Secondary Outcomes

  • State anxiety(10 minutes pre and 10 minutes post intervention)
  • Patient-provider communication(Single measure, video recording of medical consultation lasting approximately one hour)
  • Time requirements, ease of use(Single measure, after collection of all patient data)
  • Congruence between children's reported symptoms and problems and those addressed by their clinicians as evidenced in documented patient care.(Single measure, ten minutes post intervention)

Study Sites (1)

Loading locations...

Similar Trials